Spain’s Horizons Optical raised funds to develop and distribute tech for ophthalmic industry
Summary
Barcelona-based Horizons Optical, a provider of medical software used in the manufacturing of premium spectacle lenses, announced that it has secured fresh funding from London’s Oakley Capital, a pan-European mid-market private equity investor. Oakley Capital’s Origin Fund I will secure a majority stake in Horizons Optical, with CEO Santiago Soler maintaining a substantial share and continuing to lead the company. “Creating value for the optical industry” This technology is used by independent laboratories globally to produce customised ‘progressive’ lenses capable of correcting various eye conditions, such as short, mid, and far-sightedness, along with astigmatism, all within a single lens. Moreover, Horizons Optical also offers opticians equipment capable of scanning consumers’ faces and measuring pertinent facial parameters, facilitating the production of customised lenses and frames. Speaking about the latest deal, Alfredo Bru, co-founder of Sherpa Capital says, “This transaction reflects the result of working closely with the company, deeply understanding the business, and identifying new opportunities within the sector to maximise the firm’s value.